IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GANDELLINI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.029
AS - Asia 4.007
EU - Europa 3.374
SA - Sud America 379
AF - Africa 94
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.913
CN - Cina 1.363
SG - Singapore 1.297
DE - Germania 831
IT - Italia 793
GB - Regno Unito 543
HK - Hong Kong 357
RU - Federazione Russa 296
BR - Brasile 279
VN - Vietnam 220
IN - India 216
SE - Svezia 183
FR - Francia 180
IE - Irlanda 108
NL - Olanda 108
BD - Bangladesh 103
JP - Giappone 91
ID - Indonesia 84
DK - Danimarca 80
CA - Canada 62
FI - Finlandia 59
KR - Corea 54
AU - Australia 37
PL - Polonia 32
PK - Pakistan 31
TR - Turchia 30
AT - Austria 29
UA - Ucraina 29
AR - Argentina 27
MX - Messico 26
TW - Taiwan 24
CI - Costa d'Avorio 23
IQ - Iraq 20
ZA - Sudafrica 19
CO - Colombia 18
SA - Arabia Saudita 18
IR - Iran 17
ES - Italia 16
NO - Norvegia 16
CH - Svizzera 15
CL - Cile 15
BE - Belgio 14
KE - Kenya 13
PH - Filippine 11
VE - Venezuela 11
EC - Ecuador 10
EG - Egitto 10
IL - Israele 9
MY - Malesia 8
PE - Perù 7
TN - Tunisia 7
UZ - Uzbekistan 7
GR - Grecia 6
JO - Giordania 6
MA - Marocco 6
AL - Albania 5
JM - Giamaica 5
MM - Myanmar 5
OM - Oman 5
PT - Portogallo 5
PY - Paraguay 5
RO - Romania 5
SC - Seychelles 5
TH - Thailandia 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
HR - Croazia 4
UY - Uruguay 4
BG - Bulgaria 3
BO - Bolivia 3
BZ - Belize 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HU - Ungheria 3
KZ - Kazakistan 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
LB - Libano 2
LK - Sri Lanka 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AW - Aruba 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
Totale 11.913
Salva come PNG Salva come JPEG
Città #
Singapore 772
Frankfurt am Main 674
Ashburn 449
Southend 348
Milan 308
San Jose 290
Hong Kong 284
Fairfield 271
Chandler 223
Dallas 195
Santa Clara 189
Council Bluffs 178
Beijing 156
Houston 152
Wilmington 126
Woodbridge 120
Seattle 117
Hefei 114
Dublin 107
Princeton 103
Cambridge 94
Los Angeles 90
Ann Arbor 78
Nanjing 75
Ho Chi Minh City 71
Jakarta 71
Lauterbourg 70
Guangzhou 63
Boardman 62
Bengaluru 61
Shanghai 61
Dearborn 59
Moscow 56
Phoenix 52
Tokyo 49
Buffalo 42
Columbus 42
New York 42
Hanoi 41
Helsinki 38
The Dalles 37
Des Moines 36
Shenyang 35
Seoul 34
Central District 31
Rome 26
São Paulo 26
Hangzhou 24
Abidjan 23
Cangzhou 23
London 23
Dong Ket 22
Rawalpindi 22
Tianjin 22
Changsha 21
Wuhan 21
Berlin 20
Bologna 20
Jinan 20
Chengdu 19
Munich 19
Redwood City 19
San Diego 19
Turin 19
Hebei 17
Nuremberg 17
Chicago 16
Nanchang 16
Taipei 16
Vienna 16
Amsterdam 15
Catania 15
Naples 14
Montreal 13
Nairobi 12
Zhengzhou 12
Mountain View 11
Shenzhen 11
Stockholm 11
Toronto 11
Washington 11
Belo Horizonte 10
Bogotá 10
Brussels 10
Florence 10
Gdansk 10
Johannesburg 10
Lappeenranta 10
Madison 10
Xian 10
Yubileyny 10
Atlanta 9
Chongqing 9
Düsseldorf 9
Fuzhou 9
Haiphong 9
Jacksonville 9
Kunming 9
Ningbo 9
Silver Spring 9
Totale 7.389
Salva come PNG Salva come JPEG
Nome #
Reciprocal Metabolic Reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay 697
miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase C epsilon 419
LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation 364
MiR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCϵ and ZEB1 inhibition 332
Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome 302
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 292
miR-21: an oncomir on strike in prostate cancer 253
SPOP deregulation improves the radiation response of prostate cancer models by impairing DNA damage repair 241
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma 230
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables 227
Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models 225
The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action 218
Large oncosomes mediate intercellular transfer of functional microRNA 215
miR-205 regulates basement membrane deposition in human prostate: implications for cancer development 213
Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in Malignant Pleural Mesothelioma 208
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer 199
Predicting and Understanding Cancer Response to Treatment 198
Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition : persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism 197
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation 194
MiR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells 191
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 191
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma : the role of survivin 188
miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression 182
Gene expression dataset of prostate cells upon MIR205HG/LEADR modulation 182
Noncoding RNAs in the interplay between tumor cells and cancer-associated fibroblasts: Signals to catch and targets to hit 182
Navigating the Multiverse of Antisense RNAs: The Transcription- and RNA-Dependent Dimension 177
MiR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts 177
Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms 171
The MYC-induced Long Non-Coding RNA MINCR as a potential novel player in cell cycle regulation in prostate cancer 169
Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation 163
NFYA alternative cleavage and polyadenylation in cancer 158
Effective lowering of α-synuclein expression by targeting G-quadruplex structures within the SNCA gene 156
NFYC-AS1 antisense lncRNA as a potential novel player in cell cycle regulation in human cancer 155
Clusterin: A potential target for improving response to antiestrogens 150
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells 149
miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis 144
NFYA alternative cleavage and polyadenylation in cancer 143
Cellular adaptations impact the biological activity of naphthalene diimide G-quadruplex ligands in ALT-positive osteosarcoma cells 143
Targeting the telosome: Therapeutic implications 142
Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications 140
lncRNAs at the interplay between neurodegeneration and cancer: a role for MINCR 137
Complexity in the tumour microenvironment : cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types 135
MicroRNAs in Cancer Management : Big Challenges for Small Molecules 132
The pancancer overexpressed and cell cycle regulated NFYC antisense 1 controls tumor E2F/MYC proliferation programs through in cis and in trans modes of action 129
Integrating datasets to dissect NFYC-AS1 RNA- and transcription-dependent functions: comparative transcriptome profiling of knockdown strategies 128
Dissecting the role of microRNAs in prostate cancer metastasis : implications for the design of novel therapeutic approaches 126
MIR205HG/LEADR Long Noncoding RNA Binds to Primed Proximal Regulatory Regions in Prostate Basal Cells Through a Triplex- and Alu-Mediated Mechanism 125
Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype 118
Functional Study of the Noncoding Regulome of the Nuclear Factor Y 118
Cleavage and polyadenylation machinery as a novel targetable vulnerability for human cancer 113
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine 110
NFYC-AS1 antisense lncRNA as a potential novel player in cell cycle regulation in human cancer 110
Post-transcriptional control drives Aurora kinase A expression in human cancers 106
miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma 106
Deciphering the Tumor Microenvironment Composition Using Bulk Transcriptomics: A Guide to Recent Advances and Open Challenges 104
Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells 103
microRNAs as players and signals in the metastatic cascade : implications for the development of novel anti-metastatic therapies 103
MiR-1227 targets SEC23A to regulate the shedding of large extracellular vesicles 101
miRNAs in tumor radiation response : bystanders or participants? 96
MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs 95
Senescent stroma promotes prostate cancer progression : the role of miR-210 90
MicroRNAs: Cobblestones on the road to cancer metastasis 89
MicroRNA-Mediated Control of Prostate Cancer Metastasis: Implications for the Identification of Novel Biomarkers and Therapeutic Targets 89
NFYA alternative cleavage and polyadenylation in cancer 89
LEADR, a p63 target, dampens interferon signalling in bladder cancer 88
MicroRNAs as new therapeutic targets and tools in cancer 88
MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising 88
RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy 88
Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci 88
Targeting MicroRNAs to withstand cancer metastasis 87
PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells 86
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells 80
Towards the definition of prostate cancer-related microRNAs: where are we now? 77
Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment 74
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells 73
Coding the noncoding: 2 years of advances in the field of microRNAs and long noncoding RNAs 73
MicroRNAs in Prostate Cancer: A Possible Role as Novel Biomarkers and Therapeutic Targets? 72
FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic target 1
Totale 12.392
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 0 0 0 0 0 0 90
2021/2022685 41 49 35 47 60 30 41 57 85 70 51 119
2022/2023848 111 53 58 71 125 157 21 57 94 7 50 44
2023/20241.255 36 58 39 36 197 53 113 119 66 119 216 203
2024/20252.500 176 203 139 249 149 128 148 218 98 191 221 580
2025/20264.393 435 376 432 349 520 306 383 191 506 382 289 224
Totale 12.392